Predictability At Release Means Better Mr Outcomes; Pascal Platform - Pcr London Valves 2021

Predictability at release means better MR outcomes; PASCAL platform - PCR London Valves 2021

PCR

PASCAL Precision System – Accuracy and predictability interview | PCR London Valves 2023

Edwards Lifesciences Mitral & Tricuspid Therapy EU

PART 1 - Best long-term outcomes start with the first procedure - PCR London Valves 2021

PCR

PASCAL Precision System – MR symposium with live case and discussion | PCR London Valves 2022

Edwards Lifesciences Mitral & Tricuspid Therapy EU

PART 2 - Securing long-term patients' options - PCR London Valves 2021

PCR

New 2021 ESC guidelines: Impact on SMR management - PCR London Valves 2021

PCR

Seeing is believing: Predictable and durable treatment of mitral regurgitation across etiologies

PCR

Mitral repair with the PASCAL Precision system - PCR London Valves 2022

PCR

The new PASCAL Precision system unleashes the full potential of mitral TEER - PCR London Valves 2022

PCR

Intrepid early experience - PCR London Valves 2021

PCR

Innovations in TMVR and Intrepid trial updates - PCR London Valves 2022

PCR

The PASCAL platform: successfully and confidently treating MR - EuroPCR 2021

PCR

PCR London Valves 2021: ENVISAGE TAVI AF and the future of TAVI trials

CardiovascularNews

HighLife TSMVR study status and new developments - PCR London Valves 2021

PCR

PCR London Valves 2021 – Online or in person?

PCR

The remaining big questions in transcatheter tricuspid valve intervention - PCR London Valves 2023

PCR

PASCAL Precision System – TR symposium | PCR London Valves 2022

Edwards Lifesciences Mitral & Tricuspid Therapy EU

Optimising immediate and long-term outcomes after TAVI - PCR London Valves 2022

PCR